Accreditation for medical specialists is generally the responsibility of national or regional licensing bodies. Some European member states find it difficult to understand why Britain places so much emphasis on accreditation by examination. Although the standard training required to pass the MRCPath, by which accreditation is generally obtained in the United Kingdom, is unlikely to be achieved by other member states in the immediate future, it is encouraging that the Union of European Medical Specialists (UEMS) is now carrying out an extended and in-depth analysis of training in monospecialties in an attempt to improve and harmonise the quality of training.
In the United Kingdom, the balance between opportunities for specialty practice in medical microbiology at the consultant level in relation to the number of trainees is reasonably satisfactory; the Joint.Planning Advisory Committee has a specific duty to regulate this. Consequently the scope for qualified specialists applying for senior posts in Britain is limited. In some member states, however, no such arrangements exist; in West Germany there are about 4000 unemployed doctors. This situation is now compounded by the movement of doctors from East to West Germany. Indeed, the standards of training in the German Democratic Republic are generally below those in the Federal Republic. The Commission is also committed to developing harmonisation in the field of "medical devices", including various directives such as in vitro diagnostic products. This directive apparently will relate only to essential requirements; products complying will have unrestricted movement between member states from 1992.
Research

Future requirements
The undoubted complexity of the EC and its decision making process inevitably makes British pathologists, regardless of their specialty, somewhat wary of arrangements for the practice of their specialty after "1992". The EC could, however, provide additional and worthwhile dimensions for the practice of medical microbiology. Input from various national professional organisations, including the Royal College of Pathologists, is essential if various EC directives are to be moulded successfully to the practice of pathology specialties. Among issues which need to be considered are the following:
(1) Exchange of trainees Facilities already exist for interchange of research workers between member states but not for those involved in diagnostic work. Professional bodies must try to persuade the EC of the importance of such an initiative.
(2) Medical input into medical microbiology The EC must be made aware of the importance of a medical input in the running of departments of medical microbiology, with particular emphasis on the critical role of doctors interpreting results and in the organisation and implementation of infection control procedures and antimicrobial policies. Although the role of microbiologists in the above procedures is now well established in the United Kingdom, this is by no means so in many EC member states. Lack of initiative in persuading the EC of the importance of medical input may well result in pressure groups being formed by pharmacists or other groups of scientists who may wish to extend their influence in the field of diagnostic services to the detriment of patient care.
(3) Standardisation of reagents and kits In the United States diagnostic reagents and kits are extensively tested and assessed by the Food and Drug Administration (FDA) and before product licences are issued. There is no such system in Britain or in other member states. This means that organisations ofvarying degrees of sophistication, including individual laboratories, have to carry out their own assessment. This unsatisfactory state of affairs could be resolved if a European equivalent to the FDA was formed which assessed reagents and kits before a licence was provided.
